Cerebrovascular disease and statins: a potential addition to the therapeutic armamentarium for stroke prevention (Q34397848)

1 August 2017

1 reference

title

Cerebrovascular disease and statins: a potential addition to the therapeutic armamentarium for stroke prevention (English)

1 reference

1 August 2017

cerebrovascular disease

1 reference

Callahan A

1

1 reference

PubMed ID

11595197

1 August 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

American Journal of Cardiology

1 August 2017

1 reference

1 August 2017

88

1 reference

1 August 2017

7B

1 reference

1 August 2017

33J-37J

1 reference

1 August 2017

Epidemiology of stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901882-3

Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901882-3

Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901882-3

Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901882-3

Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901882-3

Stroke, statins, and cholesterol. A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901882-3

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901882-3

Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901882-3

Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901882-3

Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901882-3

10.1016/S0002-9149(01)01882-3

7 January 2021

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11595197